Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.

about

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.

Item

http://www.wikidata.org/entity/Q55193715

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Real-World Switching to Riocig ...... n Patients with PAH and CTEPH.

@en

Real-World Switching to Riocig ...... n Patients with PAH and CTEPH.

@nl

type

Item

label

Real-World Switching to Riocig ...... n Patients with PAH and CTEPH.

@en

Real-World Switching to Riocig ...... n Patients with PAH and CTEPH.

@nl

prefLabel

Real-World Switching to Riocig ...... n Patients with PAH and CTEPH.

@en

Real-World Switching to Riocig ...... n Patients with PAH and CTEPH.

@nl

P1476

Real-World Switching to Riocig ...... in Patients with PAH and CTEPH

@en

P2093

Ekkehard Grünig

http://www.w3.org/2001/XMLSchema#string

Jean-Luc Vachiéry

http://www.w3.org/2001/XMLSchema#string

Kai Vogtländer

http://www.w3.org/2001/XMLSchema#string

Lisa Mielniczuk

http://www.w3.org/2001/XMLSchema#string

Mauricio Orozco-Levi

http://www.w3.org/2001/XMLSchema#string

MiKyung Chang

http://www.w3.org/2001/XMLSchema#string

Michael Halank

http://www.w3.org/2001/XMLSchema#string

Nobuhiro Tanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Riociguat: Mode of action and clinical development in pulmonary hypertension

Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension

Chronic thromboembolic pulmonary hypertension

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.

Riociguat for the treatment of pulmonary arterial hypertension.

Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension

Transition from prostacyclin analogue infusion to oral therapy in patients with pulmonary arterial hypertension: a 5-year follow-up.

Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences.

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

P2888

s00408-018-0100-3

P304

305-312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00408-018-0100-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P50

Henning Gall

P577

2018-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101177155

http://www.w3.org/2001/XMLSchema#string

P698

29470642

http://www.w3.org/2001/XMLSchema#string

P932

5942346

http://www.w3.org/2001/XMLSchema#string